(Q43924059)

28 November 2017

title

Interferon-alpha in chronic hepatitis C infection in dialysis patients (English)

1 reference

28 November 2017

0 references

1 reference

S Huraib

1

1 reference

28 November 2017

D Tanimu

2

1 reference

28 November 2017

S A Romeh

3

1 reference

28 November 2017

K Quadri

4

1 reference

28 November 2017

G Al Ghamdi

5

1 reference

28 November 2017

A Iqbal

6

1 reference

28 November 2017

A Abdulla

7

1 reference

28 November 2017

publication date

1 July 1999

1 reference

American Journal of Kidney Diseases

28 November 2017

published in

1 reference

28 November 2017

volume

34

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

55-60

1 reference

High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Nosocomial transmission of hepatitis C virus within a British dialysis centre.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

New insights into hepatitis C virus infection of hemodialysis patients: the implications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Chronic non-A, non-B hepatitis complicated by end-stage renal failure treated with recombinant interferon alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Interferon treatment for chronic hepatitis C virus infection in uremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Efficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Interferon-alpha facilitates renal transplantation in hemodialysis patients with chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Interferon treatment of chronic active hepatitis C in patients with end-stage chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Interferon treatment for chronic hepatitis C in haemodialysis patients: suggestions based on a small series

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Interferon for non-A, non-B chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

A twelve year natural history of hepatitis C virus infection in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Hepatitis C virus infection in chronic haemodialysis patients, a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Therapy of chronic viral hepatitis: past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Hepatitis C virus genotypes are not responsible for development of serious liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Hepatitis C virus genotypes in patients with chronic liver disease and haemodialysis patients from Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970108-3

7 January 2021

10.1016/S0272-6386(99)70108-3

Identifiers

DOI

1 reference

28 November 2017

1 reference